Search Page

1

Cite

Circulating tumor cells as a clinical, diagnostic, and prognostic biomarker in breast cancer.

Gandhi K, Sharma G. Gandhi K, et al. Breast Dis. 2025 Jan-Dec;44:15581551241296776. doi: 10.1177/15581551241296776. Epub 2025 Apr 20. Breast Dis. 2025. PMID: 40253602 Free article. Review.

Cite

2

Cite

Isolated breast myeloid sarcoma: A diagnostic and therapeutic challenge. A case report and literature review.

Mahfouz HE, Dheya N, Khalifa DS, Abdelhalim GY, Maisara NA, Saleh GA, Hamdy O, Nagib RM, Abdelhakiem M, Awny S. Mahfouz HE, et al. Breast Dis. 2025 Jan-Dec;44:15581551251324069. doi: 10.1177/15581551251324069. Epub 2025 Mar 24. Breast Dis. 2025. PMID: 40127304 Free article. Review.

Cite

3

Cite

Imaging evaluation of nipple discharge: Review of literature and management considerations.

Woodard S, Ahuja K, Allen E. Woodard S, et al. Breast Dis. 2025 Jan-Dec;44:15581551241312602. doi: 10.1177/15581551241312602. Breast Dis. 2025. PMID: 39968626 Free article. Review.

Cite

4

Cite

Parametric optimization and comparative study of machine learning and deep learning algorithms for breast cancer diagnosis.

Jain P, Aggarwal S, Adam S, Imam M. Jain P, et al. Breast Dis. 2024;43(1):257-270. doi: 10.3233/BD-240018. Breast Dis. 2024. PMID: 39331085 Free PMC article.

Cite

5

Cite

Synchronous primary breast angiosarcoma with invasive ductal carcinoma.

Ben Kridis W, Lajnef M, Khanfir A. Ben Kridis W, et al. Breast Dis. 2024;43(1):271-274. doi: 10.3233/BD-240003. Breast Dis. 2024. PMID: 39302353 Free PMC article.

Cite

6

Cite

Chemotherapy induced alopecia in breast cancer patients: A monocentric prospective study.

Ben Kridis W, Boudawara O, Khanfir A. Ben Kridis W, et al. Breast Dis. 2024;43(1):251-255. doi: 10.3233/BD-240019. Breast Dis. 2024. PMID: 39213044 Free PMC article.

Cite

7

Cite

Breast gel based on Boswellia serrata, Betaine and myo-Inositol improves cyclic mastodynia in fertile women: A retrospective clinical study.

Burratti M, Morano G, Pasquale C, Di Fonso G, Costabile L. Burratti M, et al. Breast Dis. 2024;43(1):243-249. doi: 10.3233/BD-240012. Breast Dis. 2024. PMID: 39213043 Free PMC article.

Cite

8

Cite

Genomic signatures in breast cancer in a real-world setting: Experience in a Brazilian Northeastern Center.

Vieira SC, Dos Reis CA, Holanda MEF, da Silva Fontinele DR, Leal AIC, de Lima FT. Vieira SC, et al. Breast Dis. 2024;43(1):237-242. doi: 10.3233/BD-230044. Breast Dis. 2024. PMID: 38995764 Free PMC article.

Cite

9

Cite

Nipple-sparing mastectomy and immediate breast reconstruction by prepectoral implant for the management of giant phyllodes tumors: A case series.

Abdelwahab KM, Elsaeed S, Hamdy O, Saleh MM, Hosam A. Abdelwahab KM, et al. Breast Dis. 2024;43(1):231-236. doi: 10.3233/BD-240011. Breast Dis. 2024. PMID: 38968039 Free PMC article.

Cite

10

Cite

Development of neuro-Behcet's disease in a patient with operable HER2-positive breast cancer during neoadjuvant chemotherapy: A case report.

Nakai T, Seki H, Makino A, Kadota Y, Kaburagi T, Okumura T, Karahashi T. Nakai T, et al. Breast Dis. 2024;43(1):223-229. doi: 10.3233/BD-230026. Breast Dis. 2024. PMID: 38968038 Free PMC article.

Cite

11

Cite

A novel PIK3CA hot-spot mutation in breast cancer patients detected by HRM-COLD-PCR analysis.

Debouki-Joudi S, Ben Kridis W, Trifa F, Ayadi W, Khabir A, Sellami-Boudawara T, Daoud J, Khanfir A, Mokdad-Gargouri R. Debouki-Joudi S, et al. Breast Dis. 2024;43(1):213-221. doi: 10.3233/BD-240005. Breast Dis. 2024. PMID: 38943378 Free PMC article.

Cite

12

Cite

Lectins as a promising therapeutic agent for breast cancer: A review.

Singh K, Agrawal L, Gupta R, Singh D, Kathpalia M, Kaur N. Singh K, et al. Breast Dis. 2024;43(1):193-211. doi: 10.3233/BD-230047. Breast Dis. 2024. PMID: 38905027 Free PMC article. Review.

Cite

13

Cite

The quality of life assessment of breast cancer patients.

Hasanah U, Ahmad M, Prihantono P, Usman AN, Arsyad A, Agustin DI. Hasanah U, et al. Breast Dis. 2024;43(1):173-185. doi: 10.3233/BD-249008. Breast Dis. 2024. PMID: 38875026 Free PMC article.

Cite

14

Cite

Physical activity and quality of life in breast cancer survivors.

Agussalim NQ, Ahmad M, Prihantono P, Usman AN, Rafiah S, Agustin DI. Agussalim NQ, et al. Breast Dis. 2024;43(1):161-171. doi: 10.3233/BD-249005. Breast Dis. 2024. PMID: 38875025 Free PMC article.

Cite

15

Cite

Metaplastic breast cancer masquerading as a recurrent haematoma: A case report.

Png NCY, Goh WXT, Chan CW. Png NCY, et al. Breast Dis. 2024;43(1):187-191. doi: 10.3233/BD-240006. Breast Dis. 2024. PMID: 38875024 Free PMC article.

Cite

16

Cite

Erratum to: Anti-IL-8 monoclonal antibodies inhibits the autophagic activity and cancer stem cells maintenance within breast cancer tumor microenvironment.

Abou Shousha S, M Osman E, Baheeg S, Shahine Y. Abou Shousha S, et al. Breast Dis. 2024;43(1):157. doi: 10.3233/BD-241111. Breast Dis. 2024. PMID: 38820046 Free PMC article. No abstract available.

Cite

17

Cite

Erratum to: Clinical significance of Notch receptors in triple negative breast cancer.

Shah H, Mistry M, Patel N, Vora H. Shah H, et al. Breast Dis. 2024;43(1):159. doi: 10.3233/BD-229041. Breast Dis. 2024. PMID: 38820045 Free article. No abstract available.

Cite

18

Cite

Early detection of self-breast examination using smartphone breast application.

Indah N, Nilawati Usman A, Sanusi Baso Y, Syarif S, Ahmad M, Agus Mumang A. Indah N, et al. Breast Dis. 2024;43(1):135-144. doi: 10.3233/BD-249004. Breast Dis. 2024. PMID: 38820009 Free PMC article.

Cite

19

Cite

Influence of variables on breast self-examination: Potential barrier or enhancement of breast cancer prevention.

Hijrah H, Usman AN, Sanusi Baso Y, Syarif S, Ahmad M, Nulandari Z. Hijrah H, et al. Breast Dis. 2024;43(1):145-155. doi: 10.3233/BD-249001. Breast Dis. 2024. PMID: 38820008 Free PMC article.

Cite

20

Cite

Contraceptive use with breast cancer incidence in Indonesia.

Sulfiana S, Prihantono P, Usman AN, Ahmad M, Aryadi Arsyad M, Mumang AA. Sulfiana S, et al. Breast Dis. 2024;43(1):127-134. doi: 10.3233/BD-249007. Breast Dis. 2024. PMID: 38788058 Free PMC article.

Cite

21

Cite

Massage on the prevention of breast cancer through stress reduction and enhancing immune system.

Siregar Z, Usman AN, Ahmad M, Ariyandy A, Ilhamuddin I, Takko AB. Siregar Z, et al. Breast Dis. 2024;43(1):119-126. doi: 10.3233/BD-249009. Breast Dis. 2024. PMID: 38758989 Free PMC article. Review.

Cite

22

Cite

In-silico prediction of anti-breast cancer activity of ginger (Zingiber officinale) using machine learning techniques.

Gondokesumo ME, Rasyak MR. Gondokesumo ME, et al. Breast Dis. 2024;43(1):99-110. doi: 10.3233/BD-249002. Breast Dis. 2024. PMID: 38758988 Free PMC article.

Cite

23

Cite

The role of platelet rich plasma enriched fat graft for correction of deformities after conservative breast surgery.

Shaaban A, Anwar M, Ramadan R. Shaaban A, et al. Breast Dis. 2024;43(1):111-118. doi: 10.3233/BD-230057. Breast Dis. 2024. PMID: 38758987 Free PMC article. Clinical Trial.

Cite

24

Cite

PD-1/PD-L1 pathway: Current research in breast cancer.

Syamsu SA, Faruk M, Smaradania N, Sampepajung E, Pranoto AS, Irsandy F, Tammasse IFU. Syamsu SA, et al. Breast Dis. 2024;43(1):79-92. doi: 10.3233/BD-249006. Breast Dis. 2024. PMID: 38701137 Free PMC article. Review.

Cite

25

Cite

Pleiotrophin serum level and metastasis occurrence in breast cancer patients.

Ikhlas M, Ferianto D, Syamsu SA, Ganda IJ, Smaradania N, Sampepajung E, Anggita CA, Faruk M. Ikhlas M, et al. Breast Dis. 2024;43(1):93-98. doi: 10.3233/BD-249003. Breast Dis. 2024. PMID: 38701136 Free PMC article.

Cite

26

Cite

The relationship of changes in molecular subtypes with metastases and progression-free survival in breast cancer.

Amansyah F, Prihantono P, Hamid F, Syamsu SA, Pieter J Jr, Faruk M. Amansyah F, et al. Breast Dis. 2024;43(1):71-78. doi: 10.3233/BD-249000. Breast Dis. 2024. PMID: 38669518 Free PMC article.

Cite

27

Cite

Sentinel node in breast cancer as an indicator of quality in medical care: Evaluation of statistics in Colombia.

González Mariño MA. González Mariño MA. Breast Dis. 2024;43(1):65-69. doi: 10.3233/BD-230059. Breast Dis. 2024. PMID: 38607745 Free PMC article.

Cite

28

Cite

Telangiectasias induced by combination tucatinib and ado-trastuzumab emtansine in a patient with metastatic breast cancer.

Rodriguez GF, Shah A, Maderal AD. Rodriguez GF, et al. Breast Dis. 2024;43(1):61-64. doi: 10.3233/BD-230053. Breast Dis. 2024. PMID: 38578876 Free PMC article.

Cite

29

Cite

Anti-IL-8 monoclonal antibodies inhibits the autophagic activity and cancer stem cells maintenance within breast cancer tumor microenvironment.

Abou Shousha S, Osman EM, Baheeg S, Shahine Y. Abou Shousha S, et al. Breast Dis. 2024;43(1):37-49. doi: 10.3233/BD-230052. Breast Dis. 2024. PMID: 38552109 Free PMC article.

Cite

30

Cite

Primary breast sarcomas: A 13 case-series study treated in university hospital in central Tunisia over a 25-year period.

Bouguerra F, Belajouza SK, Mziou E, Zanzouri R, Chahdoura H, Tbessi S, Bouzid N, Mrad ST. Bouguerra F, et al. Breast Dis. 2024;43(1):51-59. doi: 10.3233/BD-230037. Breast Dis. 2024. PMID: 38552108 Free PMC article.

Cite

31

Cite

Cancer associated fibroblasts modulate the cytotoxicity of anti-cancer drugs in breast cancer: An in vitro study.

Kashyap D, Bhattacharya S, Irinike S, Khare S, Das A, Singh G, Bal A. Kashyap D, et al. Breast Dis. 2024;43(1):25-36. doi: 10.3233/BD-230011. Breast Dis. 2024. PMID: 38517765 Free PMC article.

Cite

32

Cite

Use of axillary ultrasound to guide breast cancer management in the genomic assay era.

Lim GH, Allen JC, Lee YS, Teo SY, Lau LC, Win T, Leong LCH. Lim GH, et al. Breast Dis. 2024;43(1):19-23. doi: 10.3233/BD-230032. Breast Dis. 2024. PMID: 38489166 Free PMC article.

Cite

33

Cite

Impact of the COVID-19 pandemic on breast cancer pathological stage at diagnosis in Tunisian patients.

Triki M, Zghal M, Ayed HB, Makni S, Bouhamed M, Fendri S, Charfi S, Boudawara T, Mellouli M. Triki M, et al. Breast Dis. 2024;43(1):9-17. doi: 10.3233/BD-230051. Breast Dis. 2024. PMID: 38363601 Free PMC article.

Cite

34

Cite

Clinicopathological analysis of 38 male patients diagnosed with breast cancer.

Sahin SI, Balci S, Guler G, Altundag K. Sahin SI, et al. Breast Dis. 2024;43(1):1-8. doi: 10.3233/BD-230050. Breast Dis. 2024. PMID: 38363600 Free PMC article.

Cite

35

Cite

Course of objectively measured physical activity and sleep in postmenopausal breast cancer survivors during the COVID-19 pandemic: A 1-year follow-up.

van Cappellen-van Maldegem SJM, Hoedjes M, de Boer MR, Nijman IL, van Valenberg HMW, Seidell JC, van de Poll-Franse LV, Buffart LM, Mols F, de Rooij BH. van Cappellen-van Maldegem SJM, et al. Breast Dis. 2023;42(1):415-427. doi: 10.3233/BD-230049. Breast Dis. 2023. PMID: 38143333 Free PMC article.

Cite

36

Cite

P53 expression correlates with low axillary tumor burden in breast cancer.

Nicolau P, Masó P, Argudo N, Jiménez M, Martínez AI, Vázquez I, Comerma L, Vernet-Tomás M. Nicolau P, et al. Breast Dis. 2023;42(1):429-435. doi: 10.3233/BD-230013. Breast Dis. 2023. PMID: 38143332 Free article.

Cite

37

Cite

Expression and promoter methylation of mitogen-activated protein kinase 1 in tumor and marginal cells of breast cancer.

Goldoost S, Zarredar H, Asadi M, Shirvaliloo M, Raeisi M. Goldoost S, et al. Breast Dis. 2023;42(1):437-445. doi: 10.3233/BD-230001. Breast Dis. 2023. PMID: 38143331 Free article.

Cite

38

Cite

Endoscopy-assisted breast conservation surgery (E-BCS) vs conventional breast conservation surgery (C-BCS) technique for the management of early breast cancer: A systematic review and meta-analysis.

Patrianagara A, Hwei LRY. Patrianagara A, et al. Breast Dis. 2023;42(1):383-393. doi: 10.3233/BD-230023. Breast Dis. 2023. PMID: 38108340 Free article.

Cite

39

Cite

Breast carcinoma presenting with upper limb lymphedema - A rare case.

Jha CK, Sinha U, Sinha M, Singh PK. Jha CK, et al. Breast Dis. 2023;42(1):395-399. doi: 10.3233/BD-230022. Breast Dis. 2023. PMID: 38108339 Free article.

Cite

40

Cite

Bilateral breast cancer and the influence of body mass index in clinicopathological features and overall survival.

Luís C, Fernandes R, Dias J, Pereira D, Firmino-Machado J, Baylina P, Fernandes R, Soares R. Luís C, et al. Breast Dis. 2023;42(1):407-414. doi: 10.3233/BD-230014. Breast Dis. 2023. PMID: 38108338 Free article.

Cite

41

Cite

Breast amyloidosis associated with Sjögren syndrome: A diagnostic pitfall in breast pathology.

Khaldi O, Ghalleb M, Jallali A, Fenniche I, Somai M, Daoud F, Boussema F, Kammoun S, Hamza K, Ayadi MA, Dhieb T. Khaldi O, et al. Breast Dis. 2023;42(1):401-405. doi: 10.3233/BD-230006. Breast Dis. 2023. PMID: 38108337 Free article.

Cite

42

Cite

Conventional standard-sized bra with prosthesis or patient's bra with customized hand-knitted external prosthesis after mastectomy: Mixed-methods evaluation of patients' preferences.

Ng RP, Allen JC, Chia YY, Lim GH. Ng RP, et al. Breast Dis. 2023;42(1):375-382. doi: 10.3233/BD-230040. Breast Dis. 2023. PMID: 38073368 Free article.

Cite

43

Cite

Eribulin in metastatic breast cancer: Real world data.

Fernández-Laguna CL, Maray I, Macia-Rivas L, Álvarez-Asteinza C, Fernández-Lastras S, Velasco Durántez V, Carbajales Álvarez M, Lozano-Blázquez A. Fernández-Laguna CL, et al. Breast Dis. 2023;42(1):349-360. doi: 10.3233/BD-230031. Breast Dis. 2023. PMID: 38073367 Free article.

Cite

44

Cite

Can paternal environmental experiences affect the breast cancer risk in offspring? A systematic review.

Bagher Hosseini N, Moosapour S, Fakhar HBZ, Nazari AR, Hasehmi MO, Hadavand F, Seraj M, Akbari ME. Bagher Hosseini N, et al. Breast Dis. 2023;42(1):361-374. doi: 10.3233/BD-220062. Breast Dis. 2023. PMID: 38073366 Free article.

Cite

45

Cite

Genomic analysis of breast cancer patients from Kerala: A novel BRCA1 mutation detected.

Dharmarajan A, Gopinath V, Keloth Nayanar S, Velandi Kunnummal S, Balasubramanian S, Roshan Valiyaparambil Gopi D. Dharmarajan A, et al. Breast Dis. 2023;42(1):341-347. doi: 10.3233/BD-220002. Breast Dis. 2023. PMID: 37980640 Free article.

Cite

46

Cite

5-year adherence to adjuvant endocrine treatment in Dutch women with early stage breast cancer: A population-based database study (2006-2016).

van den Biggelaar YJPG, Kuiper JG, van der Sangen MJC, Luiten EJT, Siesling S, van Herk-Sukel M, Voogd AC, Mesters I. van den Biggelaar YJPG, et al. Breast Dis. 2023;42(1):331-339. doi: 10.3233/BD-230024. Breast Dis. 2023. PMID: 37927248 Free article.

Cite

47

Cite

A rapidly growing fibroadenoma in a pregnant woman: A case report.

Brouwer de Koning IM, van Heusden HC, Mol SJJ, Rots ML, Draaisma WA, Bosscha K. Brouwer de Koning IM, et al. Breast Dis. 2023;42(1):325-330. doi: 10.3233/BD-230030. Breast Dis. 2023. PMID: 37899052 Free article.

Cite

48

Cite

Desmoid fibroma simulating malignant breast neoplasm: A case report and literature review.

Valente MSVS, Mota FAX, Ricciardi BB, de Carvalho Borges BM, de Lucena Feitosa ES, de Aquino PL, Valente PV. Valente MSVS, et al. Breast Dis. 2023;42(1):319-323. doi: 10.3233/BD-230028. Breast Dis. 2023. PMID: 37899051 Free article. Review.

Cite

49

Cite

A controversial ER negative PR positive molecular subtype of breast carcinoma-Report of two cases.

Chandra S, Bhasin S, Saini S. Chandra S, et al. Breast Dis. 2023;42(1):315-318. doi: 10.3233/BD-230039. Breast Dis. 2023. PMID: 37807774 Free article.

Cite

50

Cite

Observational analysis of clinical and pathological characteristics and their prognostic impact in Mexican patients with breast cancer: A multi-center study.

Gozalishvilli-Boncheva A, Gonzalez-Espinoza IR, Castro-Ponce A, Bravo-Gutiérrez OA, Juárez-Salazar G, Montes-de-Oca-Moreda RI, Aguirre-Flores E, Coyotl-Huexotl M, Orozco-Luis J, Chiquillo-Domínguez M, Garibay-Díaz JC, Aranda-Claussen JE, Ponce-de-León EA, Sánchez-Sosa S, Sabaté-Fernández M, García-Reyna JC, Cordero-Vargas C, González-Blanco MJ, Aguilar-Priego JM, Sánchez-Fernández NJ, Cortés-García CA, González-Lozada LE, Miguel-Cruz E, Ceja-Utrera FJ, Hernández-Garcia MS, Piña-Vazquez M, Aguilar-Jiménez C. Gozalishvilli-Boncheva A, et al. Breast Dis. 2023;42(1):305-313. doi: 10.3233/BD-230025. Breast Dis. 2023. PMID: 37807773 Free article.

Cite

51

Cite

Clinical presentations and outcomes of young women aged <40 yrs with Ductal carcinoma in situ.

Yan Z, Ngeow J, Allen J, Lim GH. Yan Z, et al. Breast Dis. 2023;42(1):299-303. doi: 10.3233/BD-230018. Breast Dis. 2023. PMID: 37807772 Free article.

Cite

52

Cite

Quality of life assessment of breast cancer survivors in Northern Morocco: Rural-urban disparity.

El Battioui F, El Malki F, Barrijal S. El Battioui F, et al. Breast Dis. 2023;42(1):291-298. doi: 10.3233/BD-230012. Breast Dis. 2023. PMID: 37742628 Free article.

Cite

53

Cite

Complications of severe breast deformities after a silicone injection over 20-year and a successful surgical treatment.

Tuan HT, Ngoc NA, Ai LD, Van Luat N. Tuan HT, et al. Breast Dis. 2023;42(1):285-290. doi: 10.3233/BD-230021. Breast Dis. 2023. PMID: 37638420 Free article.

Cite

54

Cite

L-asparaginase from human breast milk Lactobacillus reuteri induces apoptosis using therapeutic targets Caspase-8 and Caspase-9 in breast cancer cell line.

Hassan ZH, Auda IG, Mahdi LH. Hassan ZH, et al. Breast Dis. 2023;42(1):277-283. doi: 10.3233/BD-220074. Breast Dis. 2023. PMID: 37638419 Free article.

Cite

55

Cite

Prognostic factors of male breast cancer: A monocentric experience.

Ben Kridis W, Lajnef M, Bouattour F, Toumi N, Daoud J, Khanfir A. Ben Kridis W, et al. Breast Dis. 2023;42(1):271-275. doi: 10.3233/BD-220073. Breast Dis. 2023. PMID: 37638418 Free article.

Cite

56

Cite

The positive effects and mechanisms of honey against breast cancer.

Usman AN, Ahmad M. Usman AN, et al. Breast Dis. 2023;42(1):261-269. doi: 10.3233/BD-239005. Breast Dis. 2023. PMID: 37599514 Free article.

Cite

57

Cite

GLIS2 and CCND1 expression levels in breast cancer patients.

Sadeghi M, Gholizadeh M, Safataj N, Tahmasebivand M, Mohajeri G, Lotfi H, Bostanabad SY, Safar B, Salehi M. Sadeghi M, et al. Breast Dis. 2023;42(1):251-259. doi: 10.3233/BD-220068. Breast Dis. 2023. PMID: 37574724 Free article.

Cite

58

Cite

Borderline phyllodes tumor arising in ectopic breast tissue in the axilla: Report of a rare case with brief review of literature.

Hassan MJ, Ahmed S, Siddiqui B, Akhtar K, Anees A, Arif SH, Hasan M. Hassan MJ, et al. Breast Dis. 2023;42(1):245-249. doi: 10.3233/BD-230007. Breast Dis. 2023. PMID: 37545203 Free article. Review.

Cite

59

Cite

What is known about patient-centered care application in post-surgical breast cancer patients?

Nadia S, Rivai F, Sidin I, Pasinringi SA. Nadia S, et al. Breast Dis. 2023;42(1):233-243. doi: 10.3233/BD-239004. Breast Dis. 2023. PMID: 37522192 Free article.

Cite

60

Cite

Breast reconstruction for locally advanced breast cancer previously submitted to mastectomy and an ipsilateral thoracoabdominal dermofat (ITADE) flap.

da Costa Vieira RA, Ching AW, de Oliveira-Junior I. da Costa Vieira RA, et al. Breast Dis. 2023;42(1):229-232. doi: 10.3233/BD-220057. Breast Dis. 2023. PMID: 37522191 Free article.

Cite

61

Cite

Granular cell tumour of the breast: A case report.

Pankratjevaite L, Igbokwe MM, Benian C, Lelkaitis G. Pankratjevaite L, et al. Breast Dis. 2023;42(1):219-222. doi: 10.3233/BD-220063. Breast Dis. 2023. PMID: 37482972 Free article.

Cite

62

Cite

Breast metastases from non-primary breast malignancies: What should we know?

Santana Valenciano Á, Juez Sáez LD, Pérez Mies B, Moreno SC, Fidalgo SR, Montero JC. Santana Valenciano Á, et al. Breast Dis. 2023;42(1):223-228. doi: 10.3233/BD-220056. Breast Dis. 2023. PMID: 37482971 Free article.

Cite

63

Cite

FOXP3 regulatory T cells on prognosis of breast cancer.

Usman AN, Ahmad M, Sinrang AW, Natsir S, Takko AB, Ariyandy A, Ilhamuddin I, Eragradini AR, Hasan II, Hasyim S. Usman AN, et al. Breast Dis. 2023;42(1):213-218. doi: 10.3233/BD-239002. Breast Dis. 2023. PMID: 37458005 Free article. Review.

Cite

64

Cite

Ginger potency on the prevention and treatment of breast cancer.

Usman AN, Manju B, Ilhamuddin I, Ahmad M, Ab T, Ariyandy A, Budiaman B, Eragradini AR, Hasan II, Hashim S, Sartini S, Sinrang AW. Usman AN, et al. Breast Dis. 2023;42(1):207-212. doi: 10.3233/BD-239003. Breast Dis. 2023. PMID: 37424457 Free article. Review.

Cite

65

Cite

Comparison of tumor size, histopathological grade, and molecular subtype of breast cancer at a single center study.

Awaluddin A, Pieter J Jr, Sampepajung E, Syamsu SA, Smaradhania N, Hamid F, Prihantono P, Laidding SR, Kusuma MI, Faruk M. Awaluddin A, et al. Breast Dis. 2023;42(1):191-195. doi: 10.3233/BD-239000. Breast Dis. 2023. PMID: 37424456 Free article.

Cite

66

Cite

Breast lymphoma: General review.

Rezkallah EMN, Elsaify A, Tin SMM, Dey D, Elsaify WM. Rezkallah EMN, et al. Breast Dis. 2023;42(1):197-205. doi: 10.3233/BD-220051. Breast Dis. 2023. PMID: 37393489 Free article. Review.

Cite

67

Cite

The new potential application for Mg(II) cysteinedithiocarbamate complex with anticancer activity.

Raya I, Kartina D, Irfandi R, Sufiandi S, Wijaya RI, Prihantono P, Abdalrazaq EA, Kandeel M, Usman AN. Raya I, et al. Breast Dis. 2023;42(1):177-182. doi: 10.3233/BD-239006. Breast Dis. 2023. PMID: 37355882 Free article.

Cite

68

Cite

Study of risk factors and marker status in women with breast cancer in Brunei Darussalam.

Wong CB, Mustapa A, Matusin SNI, Abdullah MS, Usman AN, Haji Abdul Hamid MRW. Wong CB, et al. Breast Dis. 2023;42(1):183-189. doi: 10.3233/BD-239001. Breast Dis. 2023. PMID: 37355881 Free article.

Cite

69

Cite

The effect of Fas/FasL pathway blocking on apoptosis and stemness within breast cancer tumor microenvironment (preclinical study).

Abou Shousha S, Baheeg S, Ghoneim H, Zoheir M, Hemida M, Shahine Y. Abou Shousha S, et al. Breast Dis. 2023;42(1):163-176. doi: 10.3233/BD-220077. Breast Dis. 2023. PMID: 37334575 Free article.

Cite

70

Cite

Quality assessment of breast cancer studies conducted with the Delphi technique.

Patino-Hernandez D, Fernández-Ávila DG, Mauricio Muñoz-Velandia Ó, Del Socorro Moreno Luna I. Patino-Hernandez D, et al. Breast Dis. 2023;42(1):155-161. doi: 10.3233/BD-220079. Breast Dis. 2023. PMID: 37154176 Free article.

Cite

71

Cite

Pseudoangiomatous stromal hyperplasia of the breast, imaging and clinical perspective: A review.

Alikhassi A, Skarpathiotakis M, Lu FL, Curpen B. Alikhassi A, et al. Breast Dis. 2023;42(1):147-153. doi: 10.3233/BD-220072. Breast Dis. 2023. PMID: 37154175 Free article. Review.

Cite

72

Cite

Axillary reverse mapping in breast cancer: An overview.

Abbas Y, Hamdy O. Abbas Y, et al. Breast Dis. 2023;42(1):137-146. doi: 10.3233/BD-220040. Breast Dis. 2023. PMID: 37154174 Free article. Review.

Cite

73

Cite

Efficacy and safety of antibody-drug conjugates in triple-negative and HER-2 positive breast cancer: A systematic review and meta-analysis of clinical trials.

Afzal F, Aiman W, Zahoor H, Bajwa AR, Kazmi SH, Anwar A, Anwar MY, Rashid S, Zubair H, Kashif T, Ashar Ali M. Afzal F, et al. Breast Dis. 2023;42(1):121-136. doi: 10.3233/BD-220052. Breast Dis. 2023. PMID: 37125539 Free article.

Cite

74

Cite

Pseudoangiomatous stromal hyperplasia of the breast: Clinical evaluation.

Esmer AC, Tazeoglu D, Dag A. Esmer AC, et al. Breast Dis. 2023;42(1):115-119. doi: 10.3233/BD-220070. Breast Dis. 2023. PMID: 37066901 Free article.

Cite

75

Cite

The epidemiological and clinicopathological characteristics of multifocal/multicentric breast cancer in the Egyptian Delta and its impact on management strategies.

Abdallah A, Hamdy O, Zuhdy M, Elbalka SS, Abdelkhalek M, Zaid AM, Atef A, Elmadawy MG, Refky B, Wahab KA, Bayoumi D, Ali KM, Metwally IH, Shetiwy M. Abdallah A, et al. Breast Dis. 2023;42(1):101-114. doi: 10.3233/BD-220066. Breast Dis. 2023. PMID: 37066900 Free article.

Cite

76

Cite

Clinical significance of Notch receptors in triple negative breast cancer.

Shah H, Mistry M, Patel N, Vora H. Shah H, et al. Breast Dis. 2023;42(1):85-100. doi: 10.3233/BD-220041. Breast Dis. 2023. PMID: 36970890 Free article.

Cite

77

Cite

The role of HMGCR expression in combination therapy of simvastatin and FAC treated locally advanced breast cancer patients.

Yulian ED, Siregar NC, Sudijono B, Hwei LRY. Yulian ED, et al. Breast Dis. 2023;42(1):73-83. doi: 10.3233/BD-220021. Breast Dis. 2023. PMID: 36938720 Free article. Clinical Trial.

Cite

78

Cite

Association of DROSHA rs6877842, rs642321 and rs10719 polymorphisms with increased susceptibility to breast cancer: A case-control study with genotype and haplotype analysis.

Kamalabad ST, Zamanzadeh Z, Rezaei H, Tabatabaeian M, Abkar M. Kamalabad ST, et al. Breast Dis. 2023;42(1):45-58. doi: 10.3233/BD-220026. Breast Dis. 2023. PMID: 36911928 Free article.

Cite

79

Cite

Machine learning analysis of breast ultrasound to classify triple negative and HER2+ breast cancer subtypes.

Ferre R, Elst J, Senthilnathan S, Lagree A, Tabbarah S, Lu FI, Sadeghi-Naini A, Tran WT, Curpen B. Ferre R, et al. Breast Dis. 2023;42(1):59-66. doi: 10.3233/BD-220018. Breast Dis. 2023. PMID: 36911927 Free article.

Cite

80

Cite

Oligometastatic breast cancer to parotid gland with complete response.

Peron V, Miyasaki Piovesana M, Martins Medeiros E, André Di Ricco B, Teixeira Liutti V. Peron V, et al. Breast Dis. 2023;42(1):67-71. doi: 10.3233/BD-210049. Breast Dis. 2023. PMID: 36911926 Free article.

Cite

81

Cite

Injection mammoplasty: Normal imaging appearances, complications, and implications for mammographic screening.

Goh WXT, Lee YS, Teo SY. Goh WXT, et al. Breast Dis. 2023;42(1):37-44. doi: 10.3233/BD-220059. Breast Dis. 2023. PMID: 36872763 Free article. Review.

Cite

82

Cite

Unchartered waters: Significance of fall in Ki67 index after short-term preoperative endocrine therapy in early breast cancers.

Louis DM, Nair LM, Vijaykumar DK, Vallonthaiel AG, Yesodharan J, Bhaskaran R, Narmadha MP. Louis DM, et al. Breast Dis. 2023;42(1):27-36. doi: 10.3233/BD-220042. Breast Dis. 2023. PMID: 36872762 Free article.

Cite

83

Cite

Is the use of blue dye really necessary in axillary sentinel lymph node biopsy in staging of breast cancer?

Donigiewicz UJ, Banks J, Saeed M, Green M, Knight H. Donigiewicz UJ, et al. Breast Dis. 2023;42(1):23-26. doi: 10.3233/BD-220036. Breast Dis. 2023. PMID: 36872761 Free article.

Cite

84

Cite

Lymph node microcalcifications after neoadjuvant chemotherapy: A therapeutic response marker.

da Costa Vieira RA, da Rocha CA, Falcão-Junior PC, de Oliveira LCN. da Costa Vieira RA, et al. Breast Dis. 2023;42(1):17-21. doi: 10.3233/BD-220025. Breast Dis. 2023. PMID: 36872760 Free article.

Cite

85

Cite

Bone modifying agents in postmenopausal breast cancer patients treated with aromatase inhibitors: beyond bone protection?

Villasco A, Minella C, Bounous VE, Rosso R, Biglia N. Villasco A, et al. Breast Dis. 2023;42(1):1-4. doi: 10.3233/BD-220014. Breast Dis. 2023. PMID: 36806500 Free article.

Cite

86

Cite

Clinicopathological and imaging features of ductal carcinoma in situ in BRCA1/2 mutation carriers.

Seki A, Tsunoda H, Takei J, Suzuki M, Kanomata N, Yamauchi H. Seki A, et al. Breast Dis. 2023;42(1):5-15. doi: 10.3233/BD-220006. Breast Dis. 2023. PMID: 36806499 Free article.

Cite

87

Cite

Inter-observer agreement in the diagnosis of breast atypical ductal hyperplasia: A systematic review.

González Mariño MA. González Mariño MA. Breast Dis. 2022;41(1):545-550. doi: 10.3233/BD-220029. Breast Dis. 2022. PMID: 36683493 Free article.

Cite

88

Cite

Sonographic visibility of the UltraCorTM TwirlTM tissue marker.

Lee SYS, Win T, Lee YS, Teo SY. Lee SYS, et al. Breast Dis. 2022;41(1):535-543. doi: 10.3233/BD-210078. Breast Dis. 2022. PMID: 36683492 Free article.

Cite

89

Cite

Platelet count and breast cancer stage.

Fahdrin A, Sampepajung E, Pieter J, Kasim F, Smaradhania N, Prihantono P, Mariana N, Sampepajung D, Faruk M. Fahdrin A, et al. Breast Dis. 2022;41(1):489-493. doi: 10.3233/BD-229007. Breast Dis. 2022. PMID: 36641658 Free article.

Cite

90

Cite

Correlation analysis of HIF-1α and Ca15-3 in response to neoadjuvant chemotherapy in locally advanced breast cancer: A cohort study in Indonesia.

Manginstar C, Oley MH, Oley MC, Merung M, Langi FLFG, Kepel BJ, Rusli LV, Islam AA, Faruk M. Manginstar C, et al. Breast Dis. 2022;41(1):481-487. doi: 10.3233/BD-229004. Breast Dis. 2022. PMID: 36641657 Free article.

Cite

91

Cite

Prognostic value of androgen receptor expression in different molecular types of breast cancer in women.

Elbalka SS, Metwally IH, Hassan A, Eladl AE, Shoman AM, Jawad M, Shahda E, Abdelkhalek M. Elbalka SS, et al. Breast Dis. 2022;41(1):495-502. doi: 10.3233/BD-220037. Breast Dis. 2022. PMID: 36641656 Free article.

Cite

92

Cite

Prognostic factors in inflammatory breast cancer: A single-center study.

Kridis WB, Feki A, Khmiri S, Toumi N, Chaabene K, Daoud J, Ayedi I, Khanfir A. Kridis WB, et al. Breast Dis. 2022;41(1):461-469. doi: 10.3233/BD-220034. Breast Dis. 2022. PMID: 36641655 Free article.

Cite

93

Cite

Downregulation of MICA/B tumor surface expressions and augmented soluble MICA serum levels correlate with disease stage in breast cancer.

Kshersagar J, Damle MN, Bedge P, Jagdale R, Tardalkar K, Jadhav D, Jagadale S, Toro Y, Sharma R, Joshi MG. Kshersagar J, et al. Breast Dis. 2022;41(1):471-480. doi: 10.3233/BD-220023. Breast Dis. 2022. PMID: 36641654 Free article.

Cite

94

Cite

Proteome profiling of ductal carcinoma in situ.

Mosavi Z, Bashi Zadeh Fakhar H, Rezaei-Tavirani M, Akbari ME, Rostami F. Mosavi Z, et al. Breast Dis. 2022;41(1):513-520. doi: 10.3233/BD-220017. Breast Dis. 2022. PMID: 36641653 Free article.

Cite

95

Cite

A rare presentation of tuberculous adenitis mimicking metastatic breast lymphadenopathy.

Ferre R, Ghorab Z, Alikhassi A, Curpen B. Ferre R, et al. Breast Dis. 2022;41(1):529-534. doi: 10.3233/BD-220015. Breast Dis. 2022. PMID: 36641652 Free article.

Cite

96

Cite

Down-regulation of SLC16A-AS1 and LINC00900 lncRNAs in Iranian patients with breast cancer.

Dorostgoo Z, Fattahi AS, Moosavi SS, Ghafouri-Fard S, Oskooei VK. Dorostgoo Z, et al. Breast Dis. 2022;41(1):521-528. doi: 10.3233/BD-210083. Breast Dis. 2022. PMID: 36641651 Free article.

Cite

97

Cite

Vitamin D during treatment for breast cancer - the perspective of active self-help group leaders.

Muecke R, Dubois C, Micke O, Keinki C, Huebner J. Muecke R, et al. Breast Dis. 2022;41(1):503-511. doi: 10.3233/BD-210070. Breast Dis. 2022. PMID: 36641650 Free article.

Cite

98

Cite

Vascular endothelial growth factor-A expression is significantly correlated with HER2 expression in late-stage breast cancer patients.

Saputra TA, Indra I, Syamsu SA, Sampepajung E, Nelwan BJ, Hamid F, Faruk M. Saputra TA, et al. Breast Dis. 2022;41(1):433-438. doi: 10.3233/BD-229006. Breast Dis. 2022. PMID: 36617773 Free article.

Cite

99

Cite

Correlation between the expression of Ki67 and histopathological grade, tumor size, disease-free survival, and overall survival among breast cancer patients.

Leksono RB, Thabry R, Prihantono P, Nahusuly F, Kasim F, Hamdani W, Pieter J, Indra I, Syamsu SA, Faruk M. Leksono RB, et al. Breast Dis. 2022;41(1):455-460. doi: 10.3233/BD-229005. Breast Dis. 2022. PMID: 36617772 Free article.

Cite

100

Cite

Association of chemokine (CXC motif) receptor 4 expression with lymphovascular invasion and lymph node metastasis of invasive breast cancer.

Mamonto L, Nelwan BJ, Sungowati NK, Miskad UA, Cangara MH, Zainuddin AA. Mamonto L, et al. Breast Dis. 2022;41(1):447-453. doi: 10.3233/BD-229003. Breast Dis. 2022. PMID: 36617771 Free article.

Cite

101

Cite

Breastfeeding counseling changes breastfeeding behavior of babies in coastal communities in the area of Mangara Bombang community health centers, Takalar regency.

Marhaeni M, Rahmawati R, Sonda M, Noor HM, Prihantono P. Marhaeni M, et al. Breast Dis. 2022;41(1):439-445. doi: 10.3233/BD-229002. Breast Dis. 2022. PMID: 36617770 Free article.

Cite

102

Cite

Evaluation of breast cancer metastasis and mortality rates based on molecular subtype: A description study.

Kurniawan BN, Ferianto D, Pieter J Jr. Kurniawan BN, et al. Breast Dis. 2022;41(1):427-432. doi: 10.3233/BD-229000. Breast Dis. 2022. PMID: 36591651 Free article.

Cite

103

Cite

Fibroadenoma of the breast; incidence of malignancy and indicators for surgical intervention: An analysis of 1392 patients.

Elnahas W, Metwally IH, Bonna K, Youssef M, AbdAllah S, Bonna M, Ali Faried M, Atef Tira M, Hamdy O. Elnahas W, et al. Breast Dis. 2022;41(1):421-426. doi: 10.3233/BD-210074. Breast Dis. 2022. PMID: 36565097 Free article.

Cite

104

Cite

Idiopathic granulomatous mastitis: Risk factors and management.

Ramadan R, Koryem IM, Fayed H. Ramadan R, et al. Breast Dis. 2022;41(1):413-420. doi: 10.3233/BD-220047. Breast Dis. 2022. PMID: 36530069 Free article.

Cite

105

Cite

Axillary lymph node "bubbly" calcifications and body tattoo: A case series and proposed algorithm to minimize lymph node biopsies.

Yepes MM, Feliciano Y, Net J, Betancur V, Gomez-Fernandez C, Collado-Mesa F. Yepes MM, et al. Breast Dis. 2022;41(1):397-406. doi: 10.3233/BD-220011. Breast Dis. 2022. PMID: 36530068 Free article.

Cite

106

Cite

HPV-positive cervical squamous cell carcinoma metastasis to the breast, mimicking primary tumor.

de Oliveira-Junior I, Barbin FF, Watanabe AHU, Dos Reis R, da Costa Vieira RA. de Oliveira-Junior I, et al. Breast Dis. 2022;41(1):407-411. doi: 10.3233/BD-220027. Breast Dis. 2022. PMID: 36502298 Free PMC article.

Cite

107

Cite

Acute inflammatory response to multiple chemotherapy regimen in breast carcinoma: An unreported entity1.

Jha CK, Verma H, Sinha U, Singh PK. Jha CK, et al. Breast Dis. 2022;41(1):391-395. doi: 10.3233/BD-220007. Breast Dis. 2022. PMID: 36442188 Free article.

Cite

108

Cite

Expression of Interleukin-21 and Interleukin-21 receptor in lymphocytes derived from tumor-draining lymph nodes of breast cancer.

Balouchi-Anaraki S, Mohammadsadeghi S, Norouzian M, Rasolmali R, Talei AR, Mehdipour F, Ghaderi A. Balouchi-Anaraki S, et al. Breast Dis. 2022;41(1):373-382. doi: 10.3233/BD-220013. Breast Dis. 2022. PMID: 36189580 Free article.

Cite

109

Cite

IFNγ-IL-17-IL-22+CD4+ subset and IL-22-producing cells in tumor draining lymph nodes of patients with breast cancer.

Salmanpour A, Rezaeifard S, Kiani R, Tahmasebi S, Faghih Z, Erfani N. Salmanpour A, et al. Breast Dis. 2022;41(1):383-390. doi: 10.3233/BD-210084. Breast Dis. 2022. PMID: 36189579 Free article.

Cite

110

Cite

Erratum to: Inflammatory breast cancer with excellent response to pembrolizumab-chemotherapy combination: A case report.

Kharel Z, Nemer OP, Xi W, Upadhayaya B, Falkson CI, O'Regan RM, Dhakal A. Kharel Z, et al. Breast Dis. 2022;41(1):363. doi: 10.3233/BD-229001. Breast Dis. 2022. PMID: 36057835 Free article. No abstract available.

Cite

111

Cite

Clinico-pathologic factors associated with the occurrence of early and late metastatic spread in a cohort of breast cancer patients.

Barco I, Chabrera C, García-Fernández A, Fraile M, Giménez N, Vallejo E, Zarco P, González S, González C, Larrañaga I, Garcia-Font M. Barco I, et al. Breast Dis. 2022;41(1):365-372. doi: 10.3233/BD-210086. Breast Dis. 2022. PMID: 36057813 Free article.

Cite

112

Cite

Triple negative breast cancer and reconstruction: Predictors of recurrence, complications, and mortality.

Sogunro O, Sayyed AA, Aminpour N, Towfighi P, Maini M, Masanam M, Deldar R, Murray A, De La Cruz L, Greenwalt I, Son JD. Sogunro O, et al. Breast Dis. 2022;41(1):343-350. doi: 10.3233/BD-220005. Breast Dis. 2022. PMID: 36031887 Free article.

Cite

113

Cite

Impact of body mass index on pathological complete response and survival of breast cancer patients receiving neoadjuvant chemotherapy.

Aguiar D, Ros L, Pérez D, Croissier L, Mori M, Hernández M, Vargas AM, Galván S, Antonilli C, Saura S. Aguiar D, et al. Breast Dis. 2022;41(1):351-361. doi: 10.3233/BD-210071. Breast Dis. 2022. PMID: 36031886 Free article.

Cite

114

Cite

Loss of genes in chromosome arms 5q and 16q in breast cancer.

Voutsadakis IA. Voutsadakis IA. Breast Dis. 2022;41(1):331-341. doi: 10.3233/BD-210047. Breast Dis. 2022. PMID: 35964165 Free article.

Cite

115

Cite

Diagnostic challenges of adenomyoepithelioma: A case report.

Pankratjevaite L, Lind K, Mele M, Lelkaitis G. Pankratjevaite L, et al. Breast Dis. 2022;41(1):325-330. doi: 10.3233/BD-210077. Breast Dis. 2022. PMID: 35811510 Free article.

Cite

116

Cite

MRI background parenchymal enhancement in patients with invasive lobular carcinoma: Endocrine hormonal treatment effect.

Grubstein A, Rapson Y, Manor M, Yerushalmi R, Gavrieli S, Tamir S, Meshulam S, Atar E, Stemmer SM, Shochat T, Allweis TM. Grubstein A, et al. Breast Dis. 2022;41(1):317-323. doi: 10.3233/BD-220003. Breast Dis. 2022. PMID: 35786645 Free article.

Cite

117

Cite

Preoperative evaluation of breast cancer: Contrast-enhanced mammography versus contrast-enhanced magnetic resonance imaging: A systematic review and meta-analysis.

Shahraki Z, Ghaffari M, Nakhaie Moghadam M, Parooie F, Salarzaei M. Shahraki Z, et al. Breast Dis. 2022;41(1):303-315. doi: 10.3233/BD-210034. Breast Dis. 2022. PMID: 35754256 Free article.

Cite

118

Cite

ROS1 altered breast cancers - a distinctive molecular subtype of PR- metastatic breast cancers: Expanding the scope of targeted therapeutics.

Krishnamurthy K, Deb A, Alghamdi S, Schwartz M, Cusnir M, Sriganeshan V, Poppiti R. Krishnamurthy K, et al. Breast Dis. 2022;41(1):295-301. doi: 10.3233/BD-220001. Breast Dis. 2022. PMID: 35634843 Free article.

Cite

119

Cite

Assessment of clinical conditions associated with Mondor disease.

Ito H, Ogawa Y, Shimojo N, Kawano S. Ito H, et al. Breast Dis. 2022;41(1):273-278. doi: 10.3233/BD-210056. Breast Dis. 2022. PMID: 35634842 Free article.

Cite

120

Cite

Determinants of mammography screening in Iranian women: A systematic review and meta-analysis.

Kalan Farmanfarma K, Mahdavifar N, Kiasara SH, Hassanipour S, Salehiniya H. Kalan Farmanfarma K, et al. Breast Dis. 2022;41(1):279-294. doi: 10.3233/BD-210037. Breast Dis. 2022. PMID: 35634841 Free article.

Cite

121

Cite

Accelerated radiotherapy in patients over sixty years old after mastectomy: Acute and one-year physician-assessed toxicity and health-related quality of life.

Vakaet V, Van Hulle H, Quataert V, Deseyne P, Schoepen M, Paelinck L, Post G, Van Greveling A, Speleers B, Mareel M, De Neve W, Monten C, Veldeman L. Vakaet V, et al. Breast Dis. 2022;41(1):261-266. doi: 10.3233/BD-210080. Breast Dis. 2022. PMID: 35599462 Free article.

Cite

122

Cite

Safety and efficacy of immediate autologous breast reconstruction after mastectomy in patients undergoing neoadjuvant chemoradiotherapy for locally advanced breast cancer.

Clement Z, Egbeare D, Kollias J, Gill G, Whitfield R, Bingham J, Bochner M. Clement Z, et al. Breast Dis. 2022;41(1):267-272. doi: 10.3233/BD-210062. Breast Dis. 2022. PMID: 35599461 Free article.

Cite

123

Cite

Inflammatory breast cancer with excellent response to pembrolizumab-chemotherapy combination: A case report.

Kharel Z, Nemer OP, Xi W, Upadhayaya B, Falkson CI, O'Regan RM, Dhakal A. Kharel Z, et al. Breast Dis. 2022;41(1):255-260. doi: 10.3233/BD-210041. Breast Dis. 2022. PMID: 35599460 Free article.

Cite

124

Cite

Genetic testing for hereditary predisposition to breast cancer in the real world: Initial experience.

da Silva Fontinele DR, Assunção Ribeiro da Costa RE, da Silva Magalhães MK, Vieira SC. da Silva Fontinele DR, et al. Breast Dis. 2022;41(1):249-254. doi: 10.3233/BD-210082. Breast Dis. 2022. PMID: 35570472 Free article.

Cite

125

Cite

In vitro effect of PIK3CA/mTOR inhibition in triple-negative breast cancer subtype cell lines.

Kumar S, Bhattacharyya S, Das A, Singh G, Bal A. Kumar S, et al. Breast Dis. 2022;41(1):241-247. doi: 10.3233/BD-210066. Breast Dis. 2022. PMID: 35431224 Free article.

Cite

126

Cite

The association of human cytomegalovirus with biomarkers of inflammation and immune activation in breast cancer.

Youssry S, Hussein A, Ramadan R, Alkarmouty A, Elsheredy A. Youssry S, et al. Breast Dis. 2022;41(1):229-239. doi: 10.3233/BD-210060. Breast Dis. 2022. PMID: 35404268 Free article.

Cite

127

Cite

An integrative ultrasound-pathology approach to improve preoperative phyllodes tumor classification: A pilot study.

Locicero P, Weingertner N, Noblet V, Mondino M, Mathelin C, Molière S. Locicero P, et al. Breast Dis. 2022;41(1):221-228. doi: 10.3233/BD-210025. Breast Dis. 2022. PMID: 35404267 Free article.

Cite

128

Cite

Sonographic focally thick duct of breast found in screening, why is it concerning? A report of three cases.

Boonjunwetvat D, Rengganis AA, Manasnayakorn S, Vongsaisuwon M, Tantidolthanes W, Sampatanukul P. Boonjunwetvat D, et al. Breast Dis. 2022;41(1):215-219. doi: 10.3233/BD-210075. Breast Dis. 2022. PMID: 35094985 Free article.

Cite

129

Cite

Meta-analysis: Architectural distortion and breast MRI.

Ferre R, Kuzmiak CM. Ferre R, et al. Breast Dis. 2022;41(1):205-214. doi: 10.3233/BD-210045. Breast Dis. 2022. PMID: 35094984 Free article.

Cite

130

Cite

Intramedullary spinal cord metastasis to the cauda equina in a patient with HER2-positive metastatic breast cancer: A case report.

Oki N, Seki H, Sakurai T, Horiuchi Y, Kodaka K, Shimizu K. Oki N, et al. Breast Dis. 2022;41(1):155-161. doi: 10.3233/BD-210032. Breast Dis. 2022. PMID: 35094983 Free article.

Cite

131

Cite

Erratum to: Recent advances in the epidemiology of inflammatory breast cancer.

Levine PH, Veneroso CC. Levine PH, et al. Breast Dis. 2022;41(1):163. doi: 10.3233/BD-210914. Breast Dis. 2022. PMID: 35068469 Free article. No abstract available.

Cite

132

Cite

A new oncoplastic technique for removal of centrally located malignant tumors and reconstruction by a local dermo-glandular flap in conservative breast surgery.

Ahmed YS, Abd El Maksoud WM, Sultan MH. Ahmed YS, et al. Breast Dis. 2022;41(1):175-185. doi: 10.3233/BD-210067. Breast Dis. 2022. PMID: 35068438 Free article.

Cite

133

Cite

Idiopathic granulomatous mastitis and steroid use during the pandemic of COVID-19.

Calis H, Karabulut Z, Guler Y, Sengul S. Calis H, et al. Breast Dis. 2022;41(1):145-149. doi: 10.3233/BD-210054. Breast Dis. 2022. PMID: 35068437 Free article.

Cite

134

Cite

Breast cancer stem cell population in different molecular subtypes of breast cancer.

Gupta P, Singh V, Kumar S, Das A, Singh G, Bal A. Gupta P, et al. Breast Dis. 2022;41(1):199-203. doi: 10.3233/BD-210050. Breast Dis. 2022. PMID: 35068436 Free article.

Cite

135

Cite

Breast metastasis presenting as swelling with calcification - A case report and review of the literature.

Linn YL, Tay TKY, Tan EH, Wong JSL, Madhukumar P. Linn YL, et al. Breast Dis. 2022;41(1):151-154. doi: 10.3233/BD-210035. Breast Dis. 2022. PMID: 35068435 Free article. Review.

Cite

136

Cite

Health-related quality of life in patients with breast cancer: A systematic review and meta-analysis.

Ghanei Gheshlagh R, Mohammadnejad E, Dalvand S, Dehkordi AH. Ghanei Gheshlagh R, et al. Breast Dis. 2022;41(1):191-198. doi: 10.3233/BD-210026. Breast Dis. 2022. PMID: 35068434 Free article.

Cite

137

Cite

Role of MRI in predicting response to neo-adjuvant systemic therapy (NAST) in breast cancer.

Jafferbhoy S, Gowda S M, Kabeer KK, Mohd-Isa Z, Salehi-Bird S, Marla S, Narayanan S, Soumian S. Jafferbhoy S, et al. Breast Dis. 2022;41(1):165-173. doi: 10.3233/BD-210023. Breast Dis. 2022. PMID: 35068433 Free article.

Cite

138

Cite

Down-regulation of MEG3, PANDA and CASC2 as p53-related lncRNAs in breast cancer.

Ghafouri-Fard S, Sohrabi B, Hussen BM, Mehravaran E, Jamali E, Arsang-Jang S, Fathi M, Taheri M, Samsami M. Ghafouri-Fard S, et al. Breast Dis. 2022;41(1):137-143. doi: 10.3233/BD-210069. Breast Dis. 2022. PMID: 35034894 Free article.

Cite

139

Cite

Pancreatic metastasis of invasive ductal breast carcinoma: A potential diagnostic pitfall.

Geneş ZK, Esendağlı G, Sütcüoğlu O, Şimşek B, Özet A. Geneş ZK, et al. Breast Dis. 2022;41(1):187-189. doi: 10.3233/BD-210042. Breast Dis. 2022. PMID: 35034893 Free article.

Cite

140

Cite

Survival in metaplastic breast carcinoma: A case series.

Assunção Ribeiro da Costa RE, da Silva Fontinele DR, Medeiros PCDR, Vieira SC. Assunção Ribeiro da Costa RE, et al. Breast Dis. 2022;41(1):133-136. doi: 10.3233/BD-210040. Breast Dis. 2022. PMID: 34864646 Free article.

Cite

141

Cite

Systematic review and meta-analysis of the papillomavirus prevalence in breast cancer fresh tissues.

Gomes de Oliveira G, Gonçalves AK, Eleutério J, Pinheiro LGP. Gomes de Oliveira G, et al. Breast Dis. 2022;41(1):123-132. doi: 10.3233/BD-201032. Breast Dis. 2022. PMID: 34744058 Free article.

Cite

142

Cite

Risk factors for lymphedema after breast surgery: A prospective cohort study in the era of sentinel lymph node biopsy.

Salinas-Huertas S, Luzardo-González A, Vázquez-Gallego S, Pernas S, Falo C, Pla MJ, Gil-Gil M, Beranuy-Rodriguez M, Pérez-Montero H, Gomila-Sancho M, Manent-Molina N, Arencibia-Domínguez A, Gonzalez-Pineda B, Tormo-Collado F, Ortí-Asencio M, Terra J, Martinez-Perez E, Mestre-Jane A, Campos-Varela I, Jaraba-Armas M, Benítez-Segura A, Campos-Delgado M, Fernández-Montolí ME, Valverde-Alcántara Y, Rodríguez A, Campos G, Guma A, Ponce-Sebastià J, Planas-Balagué R, Catasús-Clavé M, García-Tejedor A. Salinas-Huertas S, et al. Breast Dis. 2022;41(1):97-108. doi: 10.3233/BD-210043. Breast Dis. 2022. PMID: 34542055 Free article.

Cite

143

Cite

Prevalence of underlying malignancies in complex cysts of the breast.

Gerets JCWL, Kool M, Simons PCG, Aarts F, Vogelaar FJ. Gerets JCWL, et al. Breast Dis. 2022;41(1):89-95. doi: 10.3233/BD-201057. Breast Dis. 2022. PMID: 34542054 Free article.

Cite

144

Cite

Effect of health care disparities on procedure selection of autologous breast reconstruction in Florida.

Huayllani MT, Torres-Guzman RA, Avila FR, Advani PP, Spaulding AC, Cochuyt JJ, Nguyen MT, Lu X, Rinker BD, Forte AJ. Huayllani MT, et al. Breast Dis. 2022;41(1):75-80. doi: 10.3233/BD-210004. Breast Dis. 2022. PMID: 34487016 Free article.

Cite

145

Cite

Breast cancer screening literacy information on online platforms: A content analysis of YouTube videos.

Brar J, Khalid A, Ferdous M, Abedin T, Turin TC. Brar J, et al. Breast Dis. 2022;41(1):81-87. doi: 10.3233/BD-201028. Breast Dis. 2022. PMID: 34487015 Free article.

Cite

146

Cite

Relationship between endocrine resistance and the periods of adjuvant endocrine treatment for hormone receptor-positive, HER2-negative breast cancer.

Yamamura J, Miyamura Y, Kamigaki S, Fujita J, Osato H, Manabe H, Tanaka Y, Shinzaki W, Hahimot Y, Ito T, Komoike Y. Yamamura J, et al. Breast Dis. 2022;41(1):109-114. doi: 10.3233/BD-210027. Breast Dis. 2022. PMID: 34420939 Free article.

Cite

147

Cite

Discordance in clinical versus pathological staging in breast cancer: Are we undermining the significance of accurate preoperative staging in the present era?

Goyal S, Jacob LA, Lokanatha D, Suresh Babu MC, Lokesh KN, Rudresha AH, Saldanha S, Amirtham U, Thottian AGF, Rajeev LK. Goyal S, et al. Breast Dis. 2022;41(1):115-121. doi: 10.3233/BD-201029. Breast Dis. 2022. PMID: 34420937 Free article.

Cite

148

Cite

The relationship between cardiac dosimetry and tumour quadrant location in left sided whole breast and chest wall adjuvant radiotherapy.

Masannat YA, Lazaraviciute G, Garbett IK, Shivakumar N, Brownlee BV, Gagliardi T, Bromiley A, Heys SD, Sharma R. Masannat YA, et al. Breast Dis. 2022;41(1):67-74. doi: 10.3233/BD-201025. Breast Dis. 2022. PMID: 34420936 Free article.

Cite

149

Cite

Breast fibroadenomas are less frequent in women with uterine fibroids.

Moini A, Eslami B, Alipour S. Moini A, et al. Breast Dis. 2022;41(1):51-54. doi: 10.3233/BD-210009. Breast Dis. 2022. PMID: 34397398 Free article.

Cite

150

Cite

Invasive ductal carcinoma mammographic findings: Correlation with age, breast composition and tumor size.

Cerimele F, Tagliati C, Salvatori F, Baldassarre S, Di Martino A, Calamita V, Pressanti GL, Mingliang Y, Giuseppetti GM, Giovagnoni A. Cerimele F, et al. Breast Dis. 2022;41(1):45-49. doi: 10.3233/BD-201072. Breast Dis. 2022. PMID: 34397397 Free article.

Cite

151

Cite

Correlation of manual semi-quantitative and automated quantitative Ki-67 proliferative index with OncotypeDXTM recurrence score in invasive breast carcinoma.

Finkelman BS, Meindl A, LaBoy C, Griffin BB, Narayan SP, Brancamp R, Siziopikou KP, Pincus JL, Blanco LZ Jr. Finkelman BS, et al. Breast Dis. 2022;41(1):55-65. doi: 10.3233/BD-201011. Breast Dis. 2022. PMID: 34397396 Free article.

Cite

152

Cite

Implant infections after breast reconstruction surgery following mastectomy: Experience from a Greek breast unit.

Michalopoulos NV, Frountzas M, Karathanasis P, Theodoropoulos C, Kolia A, Zografos CG, Triantafyllou T, Larentzakis A, Danias N, Zografos GC. Michalopoulos NV, et al. Breast Dis. 2022;41(1):37-44. doi: 10.3233/BD-201077. Breast Dis. 2022. PMID: 34334372 Free article.

Cite

153

Cite

Pectoralis major myo-parenchymal flap for local reconstruction of partial mastectomy defects: Description of a new technique.

Hussein O, Roshdy S, Hamdy O, Denewer A. Hussein O, et al. Breast Dis. 2022;41(1):31-36. doi: 10.3233/BD-201042. Breast Dis. 2022. PMID: 34275886 Free article.

Cite

154

Cite

Axillary staging should be routine in primary rhabdomyosarcoma of breast: A rare case report and review of literature.

Bharath S, Lodhi N, Yadav SK, Silodia A, Baghel A, Bhatia N. Bharath S, et al. Breast Dis. 2022;41(1):27-30. doi: 10.3233/BD-210008. Breast Dis. 2022. PMID: 34250922 Free article. Review.

Cite

155

Cite

Prediction of seroma after total mastectomy using an artificial neural network algorithm.

Tansawet A, Nakchuai P, Techapongsatorn S, Sukhvibul P, Lolak S. Tansawet A, et al. Breast Dis. 2022;41(1):21-26. doi: 10.3233/BD-201051. Breast Dis. 2022. PMID: 34250921 Free article.

Cite

156

Cite

New safer management for breast cancer patients who need neoadjuvant therapy during SARS-COVID pandemic.

Casella D, Fusario D, Neri A. Casella D, et al. Breast Dis. 2022;41(1):1-3. doi: 10.3233/BD-210007. Breast Dis. 2022. PMID: 34219707 Free article.

Cite

157

Cite

Literature review and case report of bilateral intracystic papillary carcinoma associated with an invasive ductal carcinoma in a male breast.

Avau F, Chintinne M, Baudry S, Buxant F. Avau F, et al. Breast Dis. 2022;41(1):5-13. doi: 10.3233/BD-210001. Breast Dis. 2022. PMID: 34219706 Free article. Review.

Cite

158

Cite

Top 100 cited articles in male breast cancer: A bibliometric analysis.

Kwok HT, Van M, Fan KS, Chan J. Kwok HT, et al. Breast Dis. 2022;41(1):15-20. doi: 10.3233/BD-201024. Breast Dis. 2022. PMID: 34219705 Free article. Review.

Cite

159

Cite

Aggressive malignant phyllodes tumor of breast with omental metastases - A case report.

Rajkrishna B, Balakrishnan R, Raam M, Santhosh Raj A, Sebastian P, Selvamani B. Rajkrishna B, et al. Breast Dis. 2021;40(4):287-291. doi: 10.3233/BD-201054. Breast Dis. 2021. PMID: 34420938 Free article.

Cite

160

Cite

Recent advances in the epidemiology of inflammatory breast cancer.

Levine PH, Veneroso CC. Levine PH, et al. Breast Dis. 2021;40(3):133-142. doi: 10.3233/BD-210014. Breast Dis. 2021. PMID: 34120895 Free article. Review.

Cite

161

Cite

MDCT evaluation of synchronous breast carcinoma and other solid malignancies.

El-Badrawy A. El-Badrawy A. Breast Dis. 2021;40(4):275-281. doi: 10.3233/BD-201065. Breast Dis. 2021. PMID: 34120894 Free article.

Cite

162

Cite

Breast pathology in adolescence.

de Vasconcelos Gaspar A, Melo L, Geraldes F, Belo J, Águas F. de Vasconcelos Gaspar A, et al. Breast Dis. 2021;40(4):269-274. doi: 10.3233/BD-201043. Breast Dis. 2021. PMID: 34120893 Free article.

Cite

163

Cite

The effect of Apis dorsata honey as complementary therapy on IL-37 levels and fatigue in breast cancer patients undergoing chemotherapy.

Syam Y, Prihantono P, Sjattar EL, Puspitha A, Majid S. Syam Y, et al. Breast Dis. 2021;40(S1):S129-S133. doi: 10.3233/BD-219020. Breast Dis. 2021. PMID: 34092586 Free article.

Cite

164

Cite

Association between molecular subtype of local advanced breast cancer with Ca 15-3 level.

Ruswendro D, Syamsu SA, Thabry R, Seweng A, Usman AN. Ruswendro D, et al. Breast Dis. 2021;40(S1):S119-S122. doi: 10.3233/BD-219018. Breast Dis. 2021. PMID: 34092585 Free article.

Cite

165

Cite

Correlation of AGR2 expression with the incidence of metastasis in luminal breast cancer.

Kereh DS, Pieter J, Hamdani W, Haryasena H, Sampepajung D, Prihantono P. Kereh DS, et al. Breast Dis. 2021;40(S1):S103-S107. doi: 10.3233/BD-219015. Breast Dis. 2021. PMID: 34092584 Free article.

Cite

166

Cite

A retrospective review of phyllodes tumors of the breast from a single institution.

Yuniandini A, Hamdani W, Prihantono P, Faruk M. Yuniandini A, et al. Breast Dis. 2021;40(S1):S63-S70. doi: 10.3233/BD-219009. Breast Dis. 2021. PMID: 34092583 Free article. Review.

Cite

167

Cite

The value of tumor-infiltrating lymphocytes and CD8 expression as a predictor of response to anthracycline-based neoadjuvant chemotherapy in invasive breast carcinoma of no special type.

Miskad UA, Rifai RA, Masadah R, Nelwan B, Ahmad D, Cangara H, Prihantono P, Zainuddin AA, Rahawarin H. Miskad UA, et al. Breast Dis. 2021;40(S1):S9-S14. doi: 10.3233/BD-219002. Breast Dis. 2021. PMID: 34092582 Free article.

Cite

168

Cite

Low diffusion level within a fibroadenoma as the sole sign of ductal carcinoma in situ: A case report.

Tagliati C, Lanni G, Cerimele F, Di Martino A, Calamita V, Lucidi Pressanti G, Mingliang Y, Giuseppetti GM, Argalia G, Giovagnoni A. Tagliati C, et al. Breast Dis. 2021;40(4):283-286. doi: 10.3233/BD-201080. Breast Dis. 2021. PMID: 34092581 Free article.

Cite

169

Cite

Evaluation of miRNAs 9 and 342 expressions in sera as diagnostic and prognostic biomarkers for breast cancer.

Ewida HA, Shabayek M, Seleem M. Ewida HA, et al. Breast Dis. 2021;40(4):241-250. doi: 10.3233/BD-201076. Breast Dis. 2021. PMID: 34092580 Free article.

Cite

170

Cite

The effect of IL-1β on MRP2 expression and tamoxifen toxicity in MCF-7 breast cancer cells.

Valinezhad Sani F, Alamolhodaei NS, Rashidpoor H, Gharaee ME, Behravan J, Mosaffa F. Valinezhad Sani F, et al. Breast Dis. 2021;40(4):263-268. doi: 10.3233/BD-201056. Breast Dis. 2021. PMID: 34092579 Free article.

Cite

171

Cite

Bone recurrence in early breast cancer patients: The paradox of aromatase inhibitors induced bone resorption.

Pavese F, Parisi A, Rotondaro S, Cocciolone V, Pierorazio G, Sidoni T, Verna L, Porzio G, Ficorella C, Cannita K. Pavese F, et al. Breast Dis. 2021;40(4):257-262. doi: 10.3233/BD-201036. Breast Dis. 2021. PMID: 34092578 Free article.

Cite

172

Cite

High expression of FBP1 and LDHB in fibroadenomas and invasive breast cancers.

Yustisia I, Amriani R, Cangara H, Syahrijuita S, Alfian Zainuddin A, Natsir R. Yustisia I, et al. Breast Dis. 2021;40(4):251-256. doi: 10.3233/BD-201035. Breast Dis. 2021. PMID: 34092577 Free article.

Cite

173

Cite

Association of ERα-36 expression with the de novo resistance of tamoxifen in ER-positive breast cancer.

Juliansyah A, Rahman S, Indra I, Nelwan B, Prihantono P. Juliansyah A, et al. Breast Dis. 2021;40(S1):S123-S127. doi: 10.3233/BD-219019. Breast Dis. 2021. PMID: 34057127 Free article.

Cite

174

Cite

Lipocalin 2 could predict circulating MMP9 levels in patients with breast cancer.

Bahrun U, Wildana W, Rahmawati H, Kurniawan LB, Hamdani W. Bahrun U, et al. Breast Dis. 2021;40(S1):S115-S117. doi: 10.3233/BD-219017. Breast Dis. 2021. PMID: 34057126 Free article.

Cite

175

Cite

The relationship of self-acceptance with decision making duration in cancer patient to perform mastectomy.

Setiawan AR, Tunjungsari F, Sander MA. Setiawan AR, et al. Breast Dis. 2021;40(S1):S109-S113. doi: 10.3233/BD-219016. Breast Dis. 2021. PMID: 34057125 Free article.

Cite

176

Cite

The effect of apis Dorsata honey as a complementary therapy to interleukin-6 (IL-6) levels and T lymphocytes of post-chemotherapy breast cancer patients.

Syam Y, Prihantono P, Majid S, Sjattar EL, Kana M, Usman AN. Syam Y, et al. Breast Dis. 2021;40(S1):S97-S101. doi: 10.3233/BD-219014. Breast Dis. 2021. PMID: 34057124 Free article.

Cite

177

Cite

The relationship of family support with decision-making duration in cancer patient to perform a mastectomy.

Tunjungsari F, Setiawan AR, Sander MA, Usman AN. Tunjungsari F, et al. Breast Dis. 2021;40(S1):S91-S95. doi: 10.3233/BD-219013. Breast Dis. 2021. PMID: 34057123 Free article.

Cite

178

Cite

Status of breast care during pregnancy with milk production and disease.

Nur R, Nurul Fajriah R, Larasati RD, Dirpan A, Rusydi M. Nur R, et al. Breast Dis. 2021;40(S1):S85-S89. doi: 10.3233/BD-219012. Breast Dis. 2021. PMID: 34057122 Free article.

Cite

179

Cite

Relationship between body mass index and cholesterol levels with histopathological grading of breast cancer.

Padang OS, Septiman S, Prihantono P, Soraya GV, Pieter Junior J, Syamsu SA, Sampepajung E, Faruk M. Padang OS, et al. Breast Dis. 2021;40(S1):S77-S84. doi: 10.3233/BD-219011. Breast Dis. 2021. PMID: 34057121 Free article.

Cite

180

Cite

The expression of programmed death-ligand 1 and its association with histopathological grade, stage of disease, and occurrence of metastasis in breast cancer.

Pranoto AS, Haryasena H, Prihantono P, Rahman S, Sampepajung D, Indra I, Syamsu SA, Sampepajung E, Nelwan BJ, Faruk M. Pranoto AS, et al. Breast Dis. 2021;40(S1):S71-S76. doi: 10.3233/BD-219010. Breast Dis. 2021. PMID: 34057120 Free article.

Cite

181

Cite

The comparison of Zn(II) arginine dithiocarbamate cytotoxicity in T47D breast cancer and fibroblast cells.

Prihantono P, Irfandi R, Raya I. Prihantono P, et al. Breast Dis. 2021;40(S1):S55-S61. doi: 10.3233/BD-219008. Breast Dis. 2021. PMID: 34057119 Free article.

Cite

182

Cite

Overexpression of NF-kB as a predictor of neoadjuvant chemotherapy response in breast cancer.

Sampepajung E, Hamdani W, Sampepajung D, Prihantono P. Sampepajung E, et al. Breast Dis. 2021;40(S1):S45-S53. doi: 10.3233/BD-219007. Breast Dis. 2021. PMID: 34057118 Free article.

Cite

183

Cite

Profile of anterior gradient 3 (AGR3) mRNA expression and serum levels in benign and malignant breast tumors.

Prihantono P, Rahardjo W, Syamsu SA, Smaradhania N. Prihantono P, et al. Breast Dis. 2021;40(S1):S39-S43. doi: 10.3233/BD-219006. Breast Dis. 2021. PMID: 34057117 Free article.

Cite

184

Cite

Increased aldehyde dehydrogenase 1 (ALDH1) levels are associated with chemo-responsiveness in breast cancer patients treated with taxane-adriamycin-cyclophosphamide regimen.

Hapidah H, Djabir YY, Prihantono P. Hapidah H, et al. Breast Dis. 2021;40(S1):S33-S37. doi: 10.3233/BD-219005. Breast Dis. 2021. PMID: 34057116 Free article.

Cite

185

Cite

Gata-3 and KI-67 expression in correlation with molecular subtypes of breast cancer.

Husni Cangara M, Miskad UA, Masadah R, Nelwan BJ, Wahid S. Husni Cangara M, et al. Breast Dis. 2021;40(S1):S27-S31. doi: 10.3233/BD-219004. Breast Dis. 2021. PMID: 34057115 Free article.

Cite

186

Cite

Effects of propolis and its bioactive components on breast cancer cell pathways and the molecular mechanisms involved.

Masadah R, Ikram D, Rauf S. Masadah R, et al. Breast Dis. 2021;40(S1):S15-S25. doi: 10.3233/BD-219003. Breast Dis. 2021. PMID: 34057114 Free article. Review.

Cite

187

Cite

Urokinase type plasminogen activator receptor (uPAR) and human epidermal growth factor receptor 2 (HER2) expression in metastasis of breast cancer.

Smaradhania N, Rahman S, Ardi Syamsu S, Prihantono P. Smaradhania N, et al. Breast Dis. 2021;40(S1):S1-S7. doi: 10.3233/BD-219001. Breast Dis. 2021. PMID: 34057113 Free article.

Cite

188

Cite

Reduced IL-37 gene expression and CD8 T lymphocytes in patients with metastatic breast cancer.

Farahani N, Mohagheghi F, Mosayebi G, Ghazavi A, Ganji A. Farahani N, et al. Breast Dis. 2021;40(4):235-240. doi: 10.3233/BD-201055. Breast Dis. 2021. PMID: 34024810 Free article.

Cite

189

Cite

Subtle signs of breast cancer as an important pitfall in mammographic interpretation: Establishing an accurate diagnosis in an equivocal case.

Salemis NS, Mourtzoukou E, Angelopoulos M. Salemis NS, et al. Breast Dis. 2021;40(3):213-218. doi: 10.3233/BD-201075. Breast Dis. 2021. PMID: 33935053 Free article.

Cite

190

Cite

Sentinel lymph node biopsy in breast cancer guided by CT lymphography; History, evolution and current applications.

Hamdy O, Farouk O, El-Badrawy A, Denewer A, Setit A. Hamdy O, et al. Breast Dis. 2021;40(4):219-225. doi: 10.3233/BD-201046. Breast Dis. 2021. PMID: 33935052 Free article. Review.

Cite

191

Cite

Detecting accurate tumor size across imaging modalities in breast cancer.

Sogunro O, Cashen C, Fakir S, Stausmire J, Buderer N. Sogunro O, et al. Breast Dis. 2021;40(3):177-182. doi: 10.3233/BD-201021. Breast Dis. 2021. PMID: 33935051 Free article.

Cite

192

Cite

Human cytomegalovirus and Epstein-Barr virus infections in breast cancer: A molecular study on Iranian women.

Ghaffari H, Tavakoli A, Nafissi N, Farahmand M, Ghorbani S, Moochani SS, Hashemi-Bahremani M, Alebouyeh MR, Monavari SH. Ghaffari H, et al. Breast Dis. 2021;40(4):227-233. doi: 10.3233/BD-201019. Breast Dis. 2021. PMID: 33935050 Free article.

Cite

193

Cite

Low incidence of milk fistula with continued breastfeeding following radiologic and surgical interventions on the lactating breast.

Johnson HM, Mitchell KB. Johnson HM, et al. Breast Dis. 2021;40(3):183-189. doi: 10.3233/BD-201000. Breast Dis. 2021. PMID: 33935049 Free article.

Cite

194

Cite

Mini review: The FDA-approved prescription drugs that target the MAPK signaling pathway in women with breast cancer.

Khojasteh Poor F, Keivan M, Ramazii M, Ghaedrahmati F, Anbiyaiee A, Panahandeh S, Khoshnam SE, Farzaneh M. Khojasteh Poor F, et al. Breast Dis. 2021;40(2):51-62. doi: 10.3233/BD-201063. Breast Dis. 2021. PMID: 33896802 Free article. Review.

Cite

195

Cite

Knowledge and perceived benefits of exercise among women with breast cancer in tertiary hospitals in Delta State.

Odikpo LC, Chiejina EN. Odikpo LC, et al. Breast Dis. 2021;40(2):101-108. doi: 10.3233/BD-201062. Breast Dis. 2021. PMID: 33896801 Free article.

Cite

196

Cite

Correlation of older age with severity of lymphedema in breast cancer survivors: A systematic review.

Guliyeva G, Huayllani MT, Boczar D, Avila FR, Forte AJ. Guliyeva G, et al. Breast Dis. 2021;40(3):191-197. doi: 10.3233/BD-201067. Breast Dis. 2021. PMID: 33867353 Free article.

Cite

197

Cite

An overview on breast cancer genetics and recent innovations: Literature survey.

Ramya Sree PR, Thoppil JE. Ramya Sree PR, et al. Breast Dis. 2021;40(3):143-154. doi: 10.3233/BD-201040. Breast Dis. 2021. PMID: 33867352 Free article. Review.

Cite

198

Cite

Benign cyst of the male breast. An exceedingly rare entity that may pose a diagnostic dilemma. Management and literature review.

Salemis NS. Salemis NS. Breast Dis. 2021;40(3):207-211. doi: 10.3233/BD-201064. Breast Dis. 2021. PMID: 33749635 Free article. Review.

Cite

199

Cite

Management and outcomes of phyllodes tumours - 10 year experience.

Boland PA, Ali Beegan A, Stokes M, Kell MR, Barry JM, O'Brien A, Walsh SM. Boland PA, et al. Breast Dis. 2021;40(3):171-176. doi: 10.3233/BD-201059. Breast Dis. 2021. PMID: 33749634 Free article.

Cite

200

Cite

Upgrade rates and outcomes of screen-detected atypical intraductal epithelial proliferation (AIDEP) diagnosed on core needle biopsy.

Dunne EC, Quinn EM, Stokes M, Barry JM, Kell M, Flanagan F, Kennedy MM, Walsh SM. Dunne EC, et al. Breast Dis. 2021;40(3):155-160. doi: 10.3233/BD-201031. Breast Dis. 2021. PMID: 33749633 Free article.

Cite